Exploring Biomarkers of the Carcinogenesis of Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas

RecruitingOBSERVATIONAL
Enrollment

5,000

Participants

Timeline

Start Date

July 1, 2022

Primary Completion Date

June 30, 2032

Study Completion Date

December 31, 2033

Conditions
Intraductal Papillary Mucinous Neoplasm
Interventions
OTHER

Observation

This is an observational study.

Trial Locations (1)

310009

RECRUITING

the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou

All Listed Sponsors
collaborator

The Second Hospital of Hebei Medical University

OTHER

collaborator

Second Affiliated Hospital of Nanchang University

OTHER

collaborator

Meng Chao Hepatobiliary Hospital of Fujian Medical University

OTHER

collaborator

Huizhou Municipal Central Hospital

OTHER

lead

Zhejiang University

OTHER